These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8998275)

  • 21. Soluble interleukin 2 receptor and soluble CD8 levels in previously treated human immunodeficiency virus-negative hemophiliacs multiply transfused with a monoclonal antibody-purified factor VIII concentrate.
    Smid WM; Martens A; van der Meer J; Hegge-Paping CS; Halie MR
    Transfusion; 1997 Jan; 37(1):86-9. PubMed ID: 9024495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokine profiles in schizophrenic patients treated with risperidone: a 3-month follow-up study.
    Cazzullo CL; Sacchetti E; Galluzzo A; Panariello A; Adorni A; Pegoraro M; Bosis S; Colombo F; Trabattoni D; Zagliani A; Clerici M
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jan; 26(1):33-9. PubMed ID: 11853116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma-soluble interleukin-2 and transferrin receptor in schizophrenia and major depression.
    Maes M; Meltzer HY; Buckley P; Bosmans E
    Eur Arch Psychiatry Clin Neurosci; 1995; 244(6):325-9. PubMed ID: 7772617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble interleukin-2 receptor and soluble CD8 antigen levels in serum from patients with solid tumors.
    Orditura M; De Vita F; Roscigno A; Auriemma A; Infusino S; Catalano G
    Int J Mol Med; 1998 Jul; 2(1):75-9. PubMed ID: 9854147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risperidone-induced increase of plasma norepinephrine is not correlated with symptom improvement in chronic schizophrenia.
    See RE; Fido AA; Maurice M; Ibrahim MM; Salama GM
    Biol Psychiatry; 1999 Jun; 45(12):1653-6. PubMed ID: 10376128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunosuppressive effects of clozapine and haloperidol: enhanced production of the interleukin-1 receptor antagonist.
    Song C; Lin Ah; Kenis G; Bosmans E; Maes M
    Schizophr Res; 2000 Apr; 42(2):157-64. PubMed ID: 10742653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of risperidone and haloperidol on superoxide dismutase and nitric oxide in schizophrenia.
    Zhang XY; Zhou DF; Shen YC; Zhang PY; Zhang WF; Liang J; Chen DC; Xiu MH; Kosten TA; Kosten TR
    Neuropharmacology; 2012 Apr; 62(5-6):1928-34. PubMed ID: 22227558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroleptic treatment increases soluble IL-2 receptors and decreases soluble IL-6 receptors in schizophrenia.
    Müller N; Empl M; Riedel M; Schwarz M; Ackenheil M
    Eur Arch Psychiatry Clin Neurosci; 1997; 247(6):308-13. PubMed ID: 9477010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms of the interleukin-1 gene complex in schizophrenia.
    Katila H; Hänninen K; Hurme M
    Mol Psychiatry; 1999 Mar; 4(2):179-81. PubMed ID: 10208450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
    Srivastava MD; Srivastava A; Srivastava BI
    Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of psychological stress on immune-inflammatory variables in normal humans. Part II. Altered serum concentrations of natural anti-inflammatory agents and soluble membrane antigens of monocytes and T lymphocytes.
    Song C; Kenis G; van Gastel A; Bosmans E; Lin A; de Jong R; Neels H; Scharpé S; Janca A; Yasukawa K; Maes M
    Psychiatry Res; 1999 Mar; 85(3):293-303. PubMed ID: 10333381
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlations of Kynurenic Acid, 3-Hydroxykynurenine, sIL-2R, IFN-α, and IL-4 with Clinical Symptoms During Acute Relapse of Schizophrenia.
    Szymona K; Zdzisińska B; Karakuła-Juchnowicz H; Kocki T; Kandefer-Szerszeń M; Flis M; Rosa W; Urbańska EM
    Neurotox Res; 2017 Jul; 32(1):17-26. PubMed ID: 28275903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum levels of IL-10, IL-6, IL-1ra, and sIL-2R in patients with psoriatic arthritis.
    Elkayam O; Yaron I; Shirazi I; Yaron M; Caspi D
    Rheumatol Int; 2000; 19(3):101-5. PubMed ID: 10776688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alterations in oxidative stress markers and its correlation with clinical findings in schizophrenic patients consuming perphenazine, clozapine and risperidone.
    Hendouei N; Farnia S; Mohseni F; Salehi A; Bagheri M; Shadfar F; Barzegar F; Hoseini SD; Charati JY; Shaki F
    Biomed Pharmacother; 2018 Jul; 103():965-972. PubMed ID: 29710513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of risperidone on serum cytokines.
    Kim DJ; Kim W; Yoon SJ; Go HJ; Choi BM; Jun TY; Kim YK
    Int J Neurosci; 2001; 111(1-2):11-9. PubMed ID: 11913333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased in vitro production of interferon-gamma and interleukin-2 in whole blood of patients with schizophrenia during treatment.
    Arolt V; Rothermundt M; Wandinger KP; Kirchner H
    Mol Psychiatry; 2000 Mar; 5(2):150-8. PubMed ID: 10822342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-6, IL-18, sIL-2R, and TNFα proinflammatory markers in depression and schizophrenia patients who are free of overt inflammation.
    Al-Hakeim HK; Al-Rammahi DA; Al-Dujaili AH
    J Affect Disord; 2015 Aug; 182():106-14. PubMed ID: 25985379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strikingly higher interleukin (IL)-1alpha, IL-1beta and soluble interleukin-1 receptor antagonist (sIL-1RA) but similar IL-2, sIL-2R, IL-3, IL-4, IL-6, sIL-6R, IL-10, tumour necrosis factor (TNF)-alpha, transforming growth factor (TGF)-beta and interferon IFN-gamma urine levels in healthy females compared to healthy males: protection against urinary tract injury?
    Sadeghi M; Daniel V; Naujokat C; Weimer R; Opelz G
    Clin Exp Immunol; 2005 Nov; 142(2):312-7. PubMed ID: 16232218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacologic and pharmacokinetic considerations in choosing an antipsychotic.
    Ereshefsky L
    J Clin Psychiatry; 1999; 60 Suppl 10():20-30. PubMed ID: 10340684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment.
    de Witte L; Tomasik J; Schwarz E; Guest PC; Rahmoune H; Kahn RS; Bahn S
    Schizophr Res; 2014 Apr; 154(1-3):23-9. PubMed ID: 24582037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.